Total Count

621

Vital Count

14

Priority Normal Stock Count

607

MSD's Availability
Vital
Priority
Institution's Availability
Vital
Priority
Total Cases (2024)

44,160

2024

December

217

November

1,767

October

2,627

September

3,341

August

3,573

July

3,957

June

3,856

May

2,425

April

2,115

March

3,937

February

6,025

January

10,320

Dengue Deaths in 2024

2

Case Fatality Rate

0.005%

High-risk MOH Areas

126

Average Midnight Total

217

SDGs Details
#
Indicator Strip
Baseline
Latest Year
SDG Target 2030

3.1.1

Maternal mortality ratio

5.66 (2015)

29.55 (2022)

10.55 (2030)

3.1.2

Proportion of births attended by skilled health personnel

99.5 (2016)

99.9 (2022)

100.0 (2030)

3.2.1

Under-five mortality rate

12.3 (2022)

7.0 (2030)

3.2.2

Neonatal mortality rate

6.8 (2022)

4.0 (2030)

3.3.1

Number of new HIV infections

0.01 (2015)

0.01 (2022)

0.01 (2030)

3.3.2

Tuberculosis incidence per 100,000 population

65.0 (2015)

5.2 (2022)

13.0 (2030)

3.3.3

Malaria Incidence per 1000, population

0.0

0.0 (2030)

3.3.5

Number of people requiring interventions against Neglected Tropical Diseases (NTD)

3.4.1

Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic

2.0 (2014)

3.4.2

Suicide mortality rate by geographic regions (district), age group & sex

14.8 (2021)

3.5.1

Coverage of treatment interventions (pharmacological, psychosocial and

2.4 (2020)

17.4 (2030)

3.5.2

Harmful use of alcohol, defined according to the national context as alcohol per

4.3 (2016)

4.63 (2021)

3.0 (2030)

3.6.1

Death rate due to road traffic injuries

11.2 (2021)

10.74 (2030)

3.7.1

Proportion of women of reproductive age (aged 15- 49 years) who have their

74.22 (2016)

80.3 (2022)

6.0 (2030)

3.7.2

Adolescent birth rate (aged 10-14 years; aged 15-19 years) per 1,000 women in

30.0 (2016)

25.0 (2030)

3.8.1

Coverage of essential health services (defined as the average coverage of essential services

3.8.2

Proportion of population with large household expenditures on health as a share

3.8.1.2

Antenatal care coverage − at least four visits (%)

98.8 (2016)

98.9 (2016)

100.0 (2030)

3.8.1.3

Percentage of infants receiving three doses of diphtheria-tetanus-pertussis containing vaccine

97.0 (2016)

97.0 (2020)

100.0 (2030)

3.8.1.4

Care-seeking for symptoms of Acute Respiratory Infections (ARI)

52.3 (2016)

53.2 (2016)

3.8.1.5

TB treatment success rate

84.6 (2016)

79.4 (2021)

90.0 (2030)

3.8.1.6

Antiretroviral therapy (ART) coverage

15.3 (2016)

68.0 (2022)

90.0 (2030)

3.8.1.7

Percentage of population in malaria-endemic areas who slept under an insecticide-treated net the previous night [only for countries with high malaria burden]

3.8.1.8

Population using safely managed sanitation services

91.2 (2016)

91.2 (2016)

100.0 (2030)

3.8.1.9

Age-standardized prevalence of non-raised blood pressure (among adults aged 18+ regardless of treatment status

90.4 (2016)

90.4 (2016)

98.0 (2030)

3.8.1.10

Age-standardized prevalence of non-raised blood pressure (among adults aged 18+ regardless of treatment status

4.5 (2015)

80.0 (2030)

3.8.1.11

Age-standardized prevalence of adults >=15 years not smoking tobacco in last 30 days

74.2 (2015)

3.8.1.12

Hospital beds per capita, relative to a maximum threshold of 18 per 10,000 population

100.0 (2016)

100.0 (2021)

100.0 (2030)

3.8.1.13

Health worker density and distribution (per 1000 pop)

16.4 (2016)

50.0 (2021)

27.14 (2030)

3.8.1.14

International Health Regulations (IHR) core capacity index

70.0 (2018)

66.0 (2022)

3.9.1

Mortality rate attributed to household and ambient air pollution

89.0 (2016)

75.0 (2030)

3.9.3

Mortality rate attributed to unintentional poisoning

0.63 (2013)

0.63 (2030)

3.a.1

Age-standardized prevalence of current tobacco use among persons aged 15 years and

25.8 (2015)

10.0 (2030)

3.b.1

Proportion of the target population covered by all vaccines included in their

96.0 (2016)

99.0 (2019)

100.0 (2030)

3.c.1

Health worker density and distribution by occupation and sex

2.43 (2016)

0.17 (2021)

0.14 (2030)

3.d.1

International Health Regulations (IHR) capacity and health emergency

46.0 (2018)

66.6 (2022)

70.0 (2030)

3.b.2

Total net official development assistance to medical research and basic health sectors by

0.98 (2016)

1.2 (2030)

3.d.2

Percentage of bloodstream infections due to selected antimicrobial-resistant

56.4 (2018)

65.2 (2020)

65.2 (2030)

3.b.3

Proportion of health facilities that have a core set of relevant essential medicines

95.29 (2017)

80.26 (2030)